Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pleconaril for Neonatal Enteroviral Sepsis
NCT00031512Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Jun 2001
- Primary completion
- Sep 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 2, randomised, double-blind trial in sepsis comparing Pleconaril with Placebo (2 arms). Primary endpoint: Percentage of patients shedding virus from the oropharynx at 5 days. Started Jun 2001; status: completed.
02
Drugs
pleconaril
03
Conditions
sepsis
Beyond the preview
Go deeper on NCT00031512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00031512.